0001140361-21-011991.txt : 20210407 0001140361-21-011991.hdr.sgml : 20210407 20210407161522 ACCESSION NUMBER: 0001140361-21-011991 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210405 FILED AS OF DATE: 20210407 DATE AS OF CHANGE: 20210407 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Georgantas Robert William III CENTRAL INDEX KEY: 0001827728 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39659 FILM NUMBER: 21812280 MAIL ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIODESIX INC CENTRAL INDEX KEY: 0001439725 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 203986492 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 303-417-0500 MAIL ADDRESS: STREET 1: 2970 WILDERNESS PLACE STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 4 1 form4.xml X0306 4 2021-04-05 0001439725 BIODESIX INC BDSX 0001827728 Georgantas Robert William III 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 true true SVP, Rsrch & Trans'l Science Common Stock 2021-04-05 4 M 0 10219 0.77 A 10774 D Common Stock 100 I By UGMA Account Stock Option (Right to buy) 0.77 2021-04-05 4 M 0 10219 0 D 2030-04-14 Common Stock 10219 19262 D This option vests 20% on January 1, 2021, and the remaining 80% in 48 successive, equal monthly installments measured from January 1, 2021. This Form 4 corrects the exercise price previously reported as $0.78 on the Form 3 filed on October 27, 2020. /s/ Robin H. Cowie as Attorney-in-Fact for Robert Georgantas III 2021-04-07